PAA 7.89% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1231

  1. 1,073 Posts.
    lightbulb Created with Sketch. 192
    Yes that what I’m being lead to think, JC is the “interim” CEO, they haven’t communicated any urgency to recruit a new CEO, perhaps once the ODD is awarded there will be no need, leaves us all guessing what we don’t know.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.